ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug gentulizumab tested for tough blood cancers – but trial halted early
Disease control TerminatedThis early-stage trial tested a new drug called gentulizumab in 58 people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that had come back or stopped responding to treatment. Gentulizumab is an antibody that helps the immune system attack cancer cells. The m…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Stem cell transplant study halted early: which prep works best?
Disease control TerminatedThis study tested two different drug combinations given before a stem cell transplant for people with myeloid blood cancers like leukemia. One group got fludarabine and busulfan, the other got those drugs plus low-dose total body irradiation. The goal was to see which regimen led…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New transplant method shows promise for tough blood cancers
Disease control TerminatedThis study tested a bone marrow transplant using a partially matched family donor for people with blood cancers like leukemia. The goal was to see if a milder conditioning regimen and a drug called cyclophosphamide could help patients survive at least 180 days after transplant. T…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC